Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Salerno

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Journal of Internal Medicine|November 30, 2020
Patterns of repeated diagnostic testing for COVID-19 in relation to patient characteristics and outcomesS Salerno, Z Zhao, S Prabhu Sankar, et al.
JPRAS Open|June 26, 2023
Long-term scarring outcomes and safety of patients treated with NovoSorb<sup>Ⓡ</sup> Biodegradable Temporizing Matrix (BTM): An observational cohort studyC H Lo, M J D Wagstaff, T M Barker, et al.
Analytica Chimica Acta|May 21, 2024
Development of an analytical platform for the affinity screening of natural extracts by SEC-MS towards PPARα and PPARγ receptorsG De Soricellis, F Rinaldi, S Tengattini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotypeV Bazan, M Migliavacca, I Zanna, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|February 15, 2020
A Process of Acceptance of Patient Photographs in Electronic Medical Records to Confirm Patient IdentificationSayedObaidullah Aseem, Basem M Ratrout, Scott C Litin, et al.
Journal of Cancer Research and Clinical Oncology|December 11, 2002
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective studyV Bazan, M Migliavacca, I Zanna, et al.
International Journal of Cardiology|May 25, 2024
Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathyV Rella, N Maurizi, A Bernardini, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Journal of Internal Medicine|November 30, 2020
Patterns of repeated diagnostic testing for COVID-19 in relation to patient characteristics and outcomesS Salerno, Z Zhao, S Prabhu Sankar, et al.
JPRAS Open|June 26, 2023
Long-term scarring outcomes and safety of patients treated with NovoSorb<sup>Ⓡ</sup> Biodegradable Temporizing Matrix (BTM): An observational cohort studyC H Lo, M J D Wagstaff, T M Barker, et al.
Analytica Chimica Acta|May 21, 2024
Development of an analytical platform for the affinity screening of natural extracts by SEC-MS towards PPARα and PPARγ receptorsG De Soricellis, F Rinaldi, S Tengattini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotypeV Bazan, M Migliavacca, I Zanna, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|February 15, 2020
A Process of Acceptance of Patient Photographs in Electronic Medical Records to Confirm Patient IdentificationSayedObaidullah Aseem, Basem M Ratrout, Scott C Litin, et al.
Journal of Cancer Research and Clinical Oncology|December 11, 2002
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective studyV Bazan, M Migliavacca, I Zanna, et al.
International Journal of Cardiology|May 25, 2024
Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathyV Rella, N Maurizi, A Bernardini, et al.
Pageof 7